Grayslake, IL, United States of America

Christopher C Marvin

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Christopher C Marvin

Introduction

Christopher C Marvin is a notable inventor based in Grayslake, IL (US). He has made significant contributions to the field of biotherapeutics, holding a total of 5 patents. His work primarily focuses on antibody drug conjugates and immunoconjugates, which have important implications in medical treatments.

Latest Patents

Among his latest patents are the development of anti-CD19 antibody drug conjugates. This patent provides compositions and methods for using these ADCs, which are crucial in targeting specific cancer cells. Another significant patent involves glucocorticoid receptor agonist immunoconjugates, which includes glucocorticoid receptor agonists and methods for their application in therapeutic settings.

Career Highlights

Christopher has worked with prominent companies such as AbbVie Inc. and AbbVie Biotherapeutics Inc. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in the biopharmaceutical industry.

Collaborations

Throughout his career, Christopher has collaborated with esteemed colleagues, including John T Randolph and Michael McPherson. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.

Conclusion

Christopher C Marvin's contributions to the field of biotherapeutics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…